BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37603503)

  • 1. Diagnostic value of serum human epididymis protein 4, carbohydrate antigen 125 and their combination in endometrial cancer: A meta-analysis.
    Wu Q; Bai SN; Song LY; Wu WF; Han LN
    Medicine (Baltimore); 2023 Aug; 102(33):e34737. PubMed ID: 37603503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: A meta-analysis.
    Li J; Wang X; Qu W; Wang J; Jiang SW
    Clin Chim Acta; 2019 Jan; 488():215-220. PubMed ID: 30414437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Human Epididymis Protein 4 Combined with Carbohydrate Antigen 125 for Endometrial Carcinoma Diagnosis: A Meta-Analysis and Systematic Review.
    Huang GQ; Xi YY; Zhang CJ; Jiang X
    Genet Test Mol Biomarkers; 2019 Aug; 23(8):580-588. PubMed ID: 31373853
    [No Abstract]   [Full Text] [Related]  

  • 4. Meta-analysis of the diagnostic accuracy of HE4 for endometrial carcinoma.
    Liu J; Han L; Sun Q; Li Y; Niyazi M
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():404-411. PubMed ID: 32711295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum human epididymis protein 4 vs. carbohydrate antigen 125 and their combination for endometrial cancer diagnosis: a meta-analysis.
    Chen Y; Ren YL; Li N; Yi XF; Wang HY
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1974-85. PubMed ID: 27249595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human epididymis protein 4 in endometrial cancer: A meta-analysis.
    Li LM; Zhu YX; Zhong Y; Su T; Fan XM; Xi Q; Li MY; Fu J; Tan H; Liu S
    Clin Chim Acta; 2018 Jul; 482():215-223. PubMed ID: 29630870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Serum Human Epididymis Protein 4 and Carbohydrate Antigen 125 as Markers in Endometrial Cancer: A Meta-Analysis.
    Hu L; Du S; Guo W; Chen D; Li Y
    Int J Gynecol Cancer; 2016 Feb; 26(2):331-40. PubMed ID: 26807564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic accuracy of HE4 in lung cancer: a meta-analysis.
    Cheng D; Sun Y; He H
    Dis Markers; 2015; 2015():352670. PubMed ID: 25873748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
    Li F; Tie R; Chang K; Wang F; Deng S; Lu W; Yu L; Chen M
    BMC Cancer; 2012 Jun; 12():258. PubMed ID: 22712526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
    Suri A; Perumal V; Ammalli P; Suryan V; Bansal SK
    Sci Rep; 2021 Aug; 11(1):17308. PubMed ID: 34453074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
    Cui Y; Hong S; Zhu X
    Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis.
    Yang Z; Wei C; Luo Z; Li L
    Onco Targets Ther; 2013; 6():957-66. PubMed ID: 23901285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of preoperative neutrophil-lymphocyte ratio and human epididymis protein 4 in predicting lymph node metastasis in endometrial cancer patients.
    Gao M; Gao Y
    J Obstet Gynaecol Res; 2021 Feb; 47(2):515-520. PubMed ID: 33142358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of human epididymis protein 4 compared with mesothelin for ovarian cancer: a systematic review and meta-analysis.
    Lin JY; Qin JB; Li XY; Dong P; Yin BD
    Asian Pac J Cancer Prev; 2012; 13(11):5427-32. PubMed ID: 23317195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.
    Zhen S; Bian LH; Chang LL; Gao X
    Mol Clin Oncol; 2014 Jul; 2(4):559-566. PubMed ID: 24940495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of gastric filling ultrasonography in preoperative invasion depth (T stage) of gastric cancer: Meta-analysis.
    Nan M; Ye W; Liu Y; Zhang Z
    Medicine (Baltimore); 2022 Oct; 101(42):e31066. PubMed ID: 36281081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of HE4 in ovarian cancer: A meta-analysis.
    Huang J; Chen J; Huang Q
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():35-42. PubMed ID: 30317143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
    Bian J; Sun X; Li B; Ming L
    Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging an Accurate Diagnostic Method for Hepatocellular Carcinoma? A Systematic Review with Meta-Analysis.
    Yinzhong W; Xiaoxue T; Jinhui T; Pengcheng Y; Xiaoying L; Junqiang L
    Curr Med Imaging; 2022; 18(6):633-647. PubMed ID: 34533447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-21 and microRNA-30c as diagnostic biomarkers for prostate cancer: a meta-analysis.
    Zhou H; Zhu X
    Cancer Manag Res; 2019; 11():2039-2050. PubMed ID: 30881128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.